Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of convertible loans beginning balance	$ 6,760	$ 7,140
Gains (losses) recognized in other comprehensive income (loss)	1,671	(1,233)
Interest recognized in interest income, net	162	496
Foreign currency remeasurement recognized in other income (expense), net	(629)	(617)
Expected credit loss recognized in other income (expense), net	260	(260)
Conversion into preferred equity securities	(8,224)
Fair value of convertible loans ending balance	0	6,760
Contractual value of Neo Medical Convertible Loans at December 31	0	7,020
Allowance for credit loss recognized in other expense, net	0	(260)
Amortized cost basis of Neo Medical Convertible Loans at December 31	$ 0	$ 6,760